𝔖 Bobbio Scriptorium

✦ LIBER ✦

A prospective, double-blind, randomized, controlled clinical trial of ampicillin-sulbactam for preterm premature rupture of membranes in women receiving antenatal corticosteroid therapy

✍ Scribed by Stuart M. Lovett; Jonathan D. Weiss; Mary J. Diogo; Paul T. Williams; Thomas J. Garite

Book ID: 113984360
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 856 KB
Volume: 176
Category: Article
ISSN: 1097-6868
DOI: 10.1016/s0002-9378(97)70398-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Group B Streptococcus and preterm premat

Group B Streptococcus and preterm premature rupture of membranes: A randomized, double-blind clinical trial of antepartum ampicillin

✍ Ian A. Grable; Patricia M. Garcia; Dennis Perry; Michael L. Socol 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 727 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB